Prostate cancer is the second-most-common cancer in men (after skin cancer) and the second-most-common cause of cancer-related death in men (after lung cancer). Latest data from the American Cancer Society: One in nine men will be diagnosed with prostate cancer in their lifetime, and one in 41 will die from
Tag: osteonecrosis of the jaw
Because your jaw is one of the joints you use most often, dealing with jaw pain can be difficult: It can affect your ability to talk, eat, and even concentrate. Often, jaw pain is related to problems with your teeth resulting from an oral health issue or from a habit
Prostate cancer is the second-most-common cancer in men (after skin cancer) and the second-most-common cause of cancer-related death in men (after lung cancer). One in seven men will be diagnosed with prostate cancer in their lifetime.
To keep things in perspective, however, it is also one of the most survivable cancers:
The FDA has issued a warning that has the potential of affecting millions of people considering the fact that between 2005 and 2009, more than 150 million bisphosphonate prescriptions were dispensed…
In the past two decades, several medications have received FDA approval for the treatment and/or prevention of osteoporosis. With so many choices, which ones are the most effective, and what do we know now about these drugs that we didn’t know 20 years ago?
“We know that using bisphosphonates in the
With up to 54 million Americans suffering from low bone density or osteoporosis, development of a new drug to combat the condition is timely. The new therapy, a dietary supplement that is a special blend of collagen and calcium, called KoACT®, in clinical trials was found superior to calcium and
Bisphosphonates (BP) were initially developed in the 1960s, but their use in arresting bone loss began in the 1990s. They are the most commonly used medication for osteoporosis—in the U.S. alone, osteoporosis results in 1.5 million fractures per year. Alendronate (Fosamax) was the first BP drug commercially available to treat
Your bones are your body’s framework—and for many, the bone-building drugs bisphosphonates ensure a sound foundation against the impact of osteoporosis. Bisphosphonates, including the oral drugs alendronate (Fosamax®), risedronate (Actonel®) and ibandronate (Boniva®), and the intravenously (IV) administered zoledronic acid (Reclast®), have been shown to reduce the risk for fracture
When the drug companies themselves start recommending “drug holidays” for certain osteoporosis patients to reduce the risk of serious bisphosphonates side effects, it’s time to take notice.
What if you knew a common treatment approach has been shown to actually increase the risk of bone fractures? That is almost as sad as the antidepressant drugs having increased risk of suicide as one of their side effects.